Yujun Lao
Payments from drug & device makers
Across 392 payments — averaging $24.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Novartis$845
- Merck$778
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$648
- Biotronik Inc.$596
- E.r. Squibb & Sons, L.L.C.$536
- plus $5K from 28 others
What the payments were for
- Food & beverage$9,547100%
- Education$340%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 50 | $1,091 |
| Novartis | 42 | $845 |
| Merck | 32 | $778 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 28 | $648 |
| Biotronik Inc. | 44 | $596 |
| E.r. Squibb & Sons, L.L.C. | 7 | $536 |
| Johnson & Johnson | 24 | $513 |
| AOP Health US, LLC | 2 | $507 |
| AstraZeneca | 19 | $408 |
| Pfizer | 15 | $394 |
| Boehringer Ingelheim | 17 | $346 |
| Actelion Pharmaceuticals US, Inc. | 10 | $339 |
| Lilly USA, LLC | 11 | $334 |
| Alnylam Pharmaceuticals Inc. | 18 | $299 |
| Impulse Dynamics (USA) Inc. | 10 | $278 |
| Axsome Therapeutics, Inc. | 2 | $240 |
| Sanofi-aventis U.S. LLC | 9 | $208 |
| Boston Scientific | 5 | $181 |
| Lexicon Pharmaceuticals, Inc. | 4 | $181 |
| Bayer | 8 | $142 |
| Kestra Medical Technology Services, Inc. | 6 | $139 |
| Amgen | 6 | $99 |
| Irhythm Technologies, Inc. | 5 | $85 |
| Daiichi Sankyo Inc. | 3 | $81 |
| Altathera Pharmaceuticals LLC | 2 | $57 |
| Scpharmaceuticals Inc. | 3 | $56 |
| Edwards Lifesciences | 2 | $46 |
| Atricure, Inc. | 2 | $43 |
| Abbott | 1 | $21 |
| Cvrx, Inc. | 1 | $20 |
| Medtronic | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,580 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 128 | $154,537 |
| OzempicSemaglutide | 45 | $62,903 |
| MounjaroTirzepatide | 40 | $54,930 |
| EntrestoSacubitril/Valsartan | 28 | $37,327 |
| XareltoRivaroxaban | 22 | $34,219 |
| FarxigaDapagliflozin Propanediol | 33 | $29,949 |
| JardianceEmpagliflozin | 24 | $15,091 |
| MultaqDronedarone Hcl | 11 | $15,008 |
| Repatha SureclickEvolocumab | 11 | $9,280 |
| Metoprolol Succinate | 112 | $1,543 |
| Flecainide Acetate | 27 | $1,337 |
| Atorvastatin Calcium | 122 | $1,155 |
| Valsartan | 19 | $1,107 |
| Losartan Potassium | 104 | $991 |
| SotalolSotalol Hcl | 41 | $975 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $394 | $154,537128 claims |
| Novo NordiskOzempic | $1,091 | $62,90345 claims |
| Lilly USA, LLCMounjaro | $334 | $54,93040 claims |
| NovartisEntresto | $845 | $37,32728 claims |
| Johnson & JohnsonXarelto | $513 | $34,21922 claims |
| AstraZenecaFarxiga | $408 | $29,94933 claims |
| Boehringer IngelheimJardiance | $346 | $15,09124 claims |
| Sanofi-aventis U.S. LLCMultaq | $208 | $15,00811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,119 family providers in Arizona.
Other family in Mesa
- Sharon MagalonaMesa$449K
- Rebecca McCollaumMesa$149K
- Angela StuffMesa$22K
- Maria Norivic SorianoMesa$15K
- Kelly MatthewsMesa$15K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Susan SarabiaSun City West$114K
- Lindsay CarterTucson$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.